Actinohivin: specific amino acid residues essential for anti-HIV activity

Actinohivin (AH) is a microbial lectin containing 114 amino acids, which inhibits human immunodeficiency virus (HIV) infection. This effect is brought about by its specific binding to Man-α(1-2)-Man unit(s) of high-mannose type glycan (HMTG) bound to HIV gp120. The recently determined crystal struct...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antibiotics 2010-11, Vol.63 (11), p.661-665
Hauptverfasser: Takahashi, Atsushi, Inokoshi, Junji, Tsunoda, Masaru, Suzuki, Kaoru, Takenaka, Akio, Sekiguchi, Takeshi, Omura, Satoshi, Tanaka, Haruo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 665
container_issue 11
container_start_page 661
container_title Journal of antibiotics
container_volume 63
creator Takahashi, Atsushi
Inokoshi, Junji
Tsunoda, Masaru
Suzuki, Kaoru
Takenaka, Akio
Sekiguchi, Takeshi
Omura, Satoshi
Tanaka, Haruo
description Actinohivin (AH) is a microbial lectin containing 114 amino acids, which inhibits human immunodeficiency virus (HIV) infection. This effect is brought about by its specific binding to Man-α(1-2)-Man unit(s) of high-mannose type glycan (HMTG) bound to HIV gp120. The recently determined crystal structure of AH suggests that three repeated segments (the residue numbers 1–38, 39–76 and 77–114 for segments 1, 2 and 3, respectively) form three sugar-binding pockets to accommodate Man-α(1-2)-Man units. The strong specific binding of AH to gp120 is considered to be due to multivalent interaction of the three sugar-binding pockets with three HMTGs of gp120 via the ‘cluster effect’ of lectin. It remains to be seen which residues of the sugar-binding pockets are essential for acceptance of Man-α(1-2)-Man. To identify the amino acid residues critical for anti-HIV effect, we performed mutational analysis. Mutant AHs were subjected to enzyme-linked immunosorbent assay testing for gp120-binding activity and to syncytium formation assay. As a result, it was revealed that Asp15, Tyr23, Leu25, Asn28 and Tyr32 in segment 1, Tyr61 in segment 2 and Tyr99 in segment 3 are essential for anti-HIV activity. The conserved residues, Asp53, Leu63, Asn66 and Tyr70, in segment 2 and, Asp91, Leu101, Asn104 and Tyr108, in segment 3 are also necessary. Furthermore, aromatic residues at positions 23 and 32 are required for creation of potency. These data will be useful for predicting the detailed mechanism of AH-Man-α(1-2)-Man/HMTG/gp120 interaction by computational analysis and for possible development of more potent microbicides for prevention of HIV transmission.
doi_str_mv 10.1038/ja.2010.106
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_814465713</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4050397961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-1543d91fe5e6d4f97eabae66d55a7dec338d5ba8919e098094746de61a7e4af43</originalsourceid><addsrcrecordid>eNptkMtLw0AQxhdRbH2cvEvAgwdN3c0-460UtYWCF_UatrsT3ZAmdTcR-t-7tVVEPM3rN98MH0JnBI8Ipuqm0qMMfxViDw2JUiQlTOT7aIhxRlKlMjxARyFUGFNJpTpEgwwrlhGWDdFsbDrXtG_uwzW3SViBcaUziV7GZqKNs4mH4GwPIYEQoOmcrpOy9YmOaTqdvUSoi8vd-gQdlLoOcLqLx-j5_u5pMk3njw-zyXieGo7zLiWcUZuTEjgIy8pcgl5oEMJyrqUFQ6myfKFVTnLAucI5k0xYEERLYLpk9BhdbnVXvn2Pf3XF0gUDda0baPtQKMKY4JLQSF78Iau29018riBSSakox1mkrraU8W0IHspi5d1S-3VBcLExuKh0sTE4FiLS5zvNfrEE-8N-OxqB6y0Q4qh5Bf_r6D96n-xhg2k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1787783502</pqid></control><display><type>article</type><title>Actinohivin: specific amino acid residues essential for anti-HIV activity</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Takahashi, Atsushi ; Inokoshi, Junji ; Tsunoda, Masaru ; Suzuki, Kaoru ; Takenaka, Akio ; Sekiguchi, Takeshi ; Omura, Satoshi ; Tanaka, Haruo</creator><creatorcontrib>Takahashi, Atsushi ; Inokoshi, Junji ; Tsunoda, Masaru ; Suzuki, Kaoru ; Takenaka, Akio ; Sekiguchi, Takeshi ; Omura, Satoshi ; Tanaka, Haruo</creatorcontrib><description>Actinohivin (AH) is a microbial lectin containing 114 amino acids, which inhibits human immunodeficiency virus (HIV) infection. This effect is brought about by its specific binding to Man-α(1-2)-Man unit(s) of high-mannose type glycan (HMTG) bound to HIV gp120. The recently determined crystal structure of AH suggests that three repeated segments (the residue numbers 1–38, 39–76 and 77–114 for segments 1, 2 and 3, respectively) form three sugar-binding pockets to accommodate Man-α(1-2)-Man units. The strong specific binding of AH to gp120 is considered to be due to multivalent interaction of the three sugar-binding pockets with three HMTGs of gp120 via the ‘cluster effect’ of lectin. It remains to be seen which residues of the sugar-binding pockets are essential for acceptance of Man-α(1-2)-Man. To identify the amino acid residues critical for anti-HIV effect, we performed mutational analysis. Mutant AHs were subjected to enzyme-linked immunosorbent assay testing for gp120-binding activity and to syncytium formation assay. As a result, it was revealed that Asp15, Tyr23, Leu25, Asn28 and Tyr32 in segment 1, Tyr61 in segment 2 and Tyr99 in segment 3 are essential for anti-HIV activity. The conserved residues, Asp53, Leu63, Asn66 and Tyr70, in segment 2 and, Asp91, Leu101, Asn104 and Tyr108, in segment 3 are also necessary. Furthermore, aromatic residues at positions 23 and 32 are required for creation of potency. These data will be useful for predicting the detailed mechanism of AH-Man-α(1-2)-Man/HMTG/gp120 interaction by computational analysis and for possible development of more potent microbicides for prevention of HIV transmission.</description><identifier>ISSN: 0021-8820</identifier><identifier>EISSN: 1881-1469</identifier><identifier>DOI: 10.1038/ja.2010.106</identifier><identifier>PMID: 20842142</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/326/22/1295 ; 631/45/535 ; 631/45/612/1235 ; 692/699/249/1570/1901 ; Amino Acid Sequence ; Amino Acid Substitution ; Amino acids ; Anti-HIV Agents - chemistry ; Anti-HIV Agents - metabolism ; Anti-HIV Agents - pharmacology ; Bacterial Proteins - chemistry ; Bacterial Proteins - metabolism ; Bacterial Proteins - pharmacology ; Bacteriology ; Binding Sites ; Biomedical and Life Sciences ; Bioorganic Chemistry ; Enzyme-Linked Immunosorbent Assay ; HIV - drug effects ; HIV Envelope Protein gp120 - metabolism ; HIV Infections - drug therapy ; HIV Infections - virology ; Humans ; Life Sciences ; Mannose - metabolism ; Medicinal Chemistry ; Microbiology ; Mutation ; Organic Chemistry ; original-article ; Protein Binding ; Residues ; Sugar</subject><ispartof>Journal of antibiotics, 2010-11, Vol.63 (11), p.661-665</ispartof><rights>Japan Antibiotics Research Association 2010</rights><rights>Copyright Nature Publishing Group Nov 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-1543d91fe5e6d4f97eabae66d55a7dec338d5ba8919e098094746de61a7e4af43</citedby><cites>FETCH-LOGICAL-c509t-1543d91fe5e6d4f97eabae66d55a7dec338d5ba8919e098094746de61a7e4af43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20842142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takahashi, Atsushi</creatorcontrib><creatorcontrib>Inokoshi, Junji</creatorcontrib><creatorcontrib>Tsunoda, Masaru</creatorcontrib><creatorcontrib>Suzuki, Kaoru</creatorcontrib><creatorcontrib>Takenaka, Akio</creatorcontrib><creatorcontrib>Sekiguchi, Takeshi</creatorcontrib><creatorcontrib>Omura, Satoshi</creatorcontrib><creatorcontrib>Tanaka, Haruo</creatorcontrib><title>Actinohivin: specific amino acid residues essential for anti-HIV activity</title><title>Journal of antibiotics</title><addtitle>J Antibiot</addtitle><addtitle>J Antibiot (Tokyo)</addtitle><description>Actinohivin (AH) is a microbial lectin containing 114 amino acids, which inhibits human immunodeficiency virus (HIV) infection. This effect is brought about by its specific binding to Man-α(1-2)-Man unit(s) of high-mannose type glycan (HMTG) bound to HIV gp120. The recently determined crystal structure of AH suggests that three repeated segments (the residue numbers 1–38, 39–76 and 77–114 for segments 1, 2 and 3, respectively) form three sugar-binding pockets to accommodate Man-α(1-2)-Man units. The strong specific binding of AH to gp120 is considered to be due to multivalent interaction of the three sugar-binding pockets with three HMTGs of gp120 via the ‘cluster effect’ of lectin. It remains to be seen which residues of the sugar-binding pockets are essential for acceptance of Man-α(1-2)-Man. To identify the amino acid residues critical for anti-HIV effect, we performed mutational analysis. Mutant AHs were subjected to enzyme-linked immunosorbent assay testing for gp120-binding activity and to syncytium formation assay. As a result, it was revealed that Asp15, Tyr23, Leu25, Asn28 and Tyr32 in segment 1, Tyr61 in segment 2 and Tyr99 in segment 3 are essential for anti-HIV activity. The conserved residues, Asp53, Leu63, Asn66 and Tyr70, in segment 2 and, Asp91, Leu101, Asn104 and Tyr108, in segment 3 are also necessary. Furthermore, aromatic residues at positions 23 and 32 are required for creation of potency. These data will be useful for predicting the detailed mechanism of AH-Man-α(1-2)-Man/HMTG/gp120 interaction by computational analysis and for possible development of more potent microbicides for prevention of HIV transmission.</description><subject>631/326/22/1295</subject><subject>631/45/535</subject><subject>631/45/612/1235</subject><subject>692/699/249/1570/1901</subject><subject>Amino Acid Sequence</subject><subject>Amino Acid Substitution</subject><subject>Amino acids</subject><subject>Anti-HIV Agents - chemistry</subject><subject>Anti-HIV Agents - metabolism</subject><subject>Anti-HIV Agents - pharmacology</subject><subject>Bacterial Proteins - chemistry</subject><subject>Bacterial Proteins - metabolism</subject><subject>Bacterial Proteins - pharmacology</subject><subject>Bacteriology</subject><subject>Binding Sites</subject><subject>Biomedical and Life Sciences</subject><subject>Bioorganic Chemistry</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>HIV - drug effects</subject><subject>HIV Envelope Protein gp120 - metabolism</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - virology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Mannose - metabolism</subject><subject>Medicinal Chemistry</subject><subject>Microbiology</subject><subject>Mutation</subject><subject>Organic Chemistry</subject><subject>original-article</subject><subject>Protein Binding</subject><subject>Residues</subject><subject>Sugar</subject><issn>0021-8820</issn><issn>1881-1469</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkMtLw0AQxhdRbH2cvEvAgwdN3c0-460UtYWCF_UatrsT3ZAmdTcR-t-7tVVEPM3rN98MH0JnBI8Ipuqm0qMMfxViDw2JUiQlTOT7aIhxRlKlMjxARyFUGFNJpTpEgwwrlhGWDdFsbDrXtG_uwzW3SViBcaUziV7GZqKNs4mH4GwPIYEQoOmcrpOy9YmOaTqdvUSoi8vd-gQdlLoOcLqLx-j5_u5pMk3njw-zyXieGo7zLiWcUZuTEjgIy8pcgl5oEMJyrqUFQ6myfKFVTnLAucI5k0xYEERLYLpk9BhdbnVXvn2Pf3XF0gUDda0baPtQKMKY4JLQSF78Iau29018riBSSakox1mkrraU8W0IHspi5d1S-3VBcLExuKh0sTE4FiLS5zvNfrEE-8N-OxqB6y0Q4qh5Bf_r6D96n-xhg2k</recordid><startdate>20101101</startdate><enddate>20101101</enddate><creator>Takahashi, Atsushi</creator><creator>Inokoshi, Junji</creator><creator>Tsunoda, Masaru</creator><creator>Suzuki, Kaoru</creator><creator>Takenaka, Akio</creator><creator>Sekiguchi, Takeshi</creator><creator>Omura, Satoshi</creator><creator>Tanaka, Haruo</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20101101</creationdate><title>Actinohivin: specific amino acid residues essential for anti-HIV activity</title><author>Takahashi, Atsushi ; Inokoshi, Junji ; Tsunoda, Masaru ; Suzuki, Kaoru ; Takenaka, Akio ; Sekiguchi, Takeshi ; Omura, Satoshi ; Tanaka, Haruo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-1543d91fe5e6d4f97eabae66d55a7dec338d5ba8919e098094746de61a7e4af43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>631/326/22/1295</topic><topic>631/45/535</topic><topic>631/45/612/1235</topic><topic>692/699/249/1570/1901</topic><topic>Amino Acid Sequence</topic><topic>Amino Acid Substitution</topic><topic>Amino acids</topic><topic>Anti-HIV Agents - chemistry</topic><topic>Anti-HIV Agents - metabolism</topic><topic>Anti-HIV Agents - pharmacology</topic><topic>Bacterial Proteins - chemistry</topic><topic>Bacterial Proteins - metabolism</topic><topic>Bacterial Proteins - pharmacology</topic><topic>Bacteriology</topic><topic>Binding Sites</topic><topic>Biomedical and Life Sciences</topic><topic>Bioorganic Chemistry</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>HIV - drug effects</topic><topic>HIV Envelope Protein gp120 - metabolism</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - virology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Mannose - metabolism</topic><topic>Medicinal Chemistry</topic><topic>Microbiology</topic><topic>Mutation</topic><topic>Organic Chemistry</topic><topic>original-article</topic><topic>Protein Binding</topic><topic>Residues</topic><topic>Sugar</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takahashi, Atsushi</creatorcontrib><creatorcontrib>Inokoshi, Junji</creatorcontrib><creatorcontrib>Tsunoda, Masaru</creatorcontrib><creatorcontrib>Suzuki, Kaoru</creatorcontrib><creatorcontrib>Takenaka, Akio</creatorcontrib><creatorcontrib>Sekiguchi, Takeshi</creatorcontrib><creatorcontrib>Omura, Satoshi</creatorcontrib><creatorcontrib>Tanaka, Haruo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antibiotics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takahashi, Atsushi</au><au>Inokoshi, Junji</au><au>Tsunoda, Masaru</au><au>Suzuki, Kaoru</au><au>Takenaka, Akio</au><au>Sekiguchi, Takeshi</au><au>Omura, Satoshi</au><au>Tanaka, Haruo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Actinohivin: specific amino acid residues essential for anti-HIV activity</atitle><jtitle>Journal of antibiotics</jtitle><stitle>J Antibiot</stitle><addtitle>J Antibiot (Tokyo)</addtitle><date>2010-11-01</date><risdate>2010</risdate><volume>63</volume><issue>11</issue><spage>661</spage><epage>665</epage><pages>661-665</pages><issn>0021-8820</issn><eissn>1881-1469</eissn><abstract>Actinohivin (AH) is a microbial lectin containing 114 amino acids, which inhibits human immunodeficiency virus (HIV) infection. This effect is brought about by its specific binding to Man-α(1-2)-Man unit(s) of high-mannose type glycan (HMTG) bound to HIV gp120. The recently determined crystal structure of AH suggests that three repeated segments (the residue numbers 1–38, 39–76 and 77–114 for segments 1, 2 and 3, respectively) form three sugar-binding pockets to accommodate Man-α(1-2)-Man units. The strong specific binding of AH to gp120 is considered to be due to multivalent interaction of the three sugar-binding pockets with three HMTGs of gp120 via the ‘cluster effect’ of lectin. It remains to be seen which residues of the sugar-binding pockets are essential for acceptance of Man-α(1-2)-Man. To identify the amino acid residues critical for anti-HIV effect, we performed mutational analysis. Mutant AHs were subjected to enzyme-linked immunosorbent assay testing for gp120-binding activity and to syncytium formation assay. As a result, it was revealed that Asp15, Tyr23, Leu25, Asn28 and Tyr32 in segment 1, Tyr61 in segment 2 and Tyr99 in segment 3 are essential for anti-HIV activity. The conserved residues, Asp53, Leu63, Asn66 and Tyr70, in segment 2 and, Asp91, Leu101, Asn104 and Tyr108, in segment 3 are also necessary. Furthermore, aromatic residues at positions 23 and 32 are required for creation of potency. These data will be useful for predicting the detailed mechanism of AH-Man-α(1-2)-Man/HMTG/gp120 interaction by computational analysis and for possible development of more potent microbicides for prevention of HIV transmission.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>20842142</pmid><doi>10.1038/ja.2010.106</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-8820
ispartof Journal of antibiotics, 2010-11, Vol.63 (11), p.661-665
issn 0021-8820
1881-1469
language eng
recordid cdi_proquest_miscellaneous_814465713
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects 631/326/22/1295
631/45/535
631/45/612/1235
692/699/249/1570/1901
Amino Acid Sequence
Amino Acid Substitution
Amino acids
Anti-HIV Agents - chemistry
Anti-HIV Agents - metabolism
Anti-HIV Agents - pharmacology
Bacterial Proteins - chemistry
Bacterial Proteins - metabolism
Bacterial Proteins - pharmacology
Bacteriology
Binding Sites
Biomedical and Life Sciences
Bioorganic Chemistry
Enzyme-Linked Immunosorbent Assay
HIV - drug effects
HIV Envelope Protein gp120 - metabolism
HIV Infections - drug therapy
HIV Infections - virology
Humans
Life Sciences
Mannose - metabolism
Medicinal Chemistry
Microbiology
Mutation
Organic Chemistry
original-article
Protein Binding
Residues
Sugar
title Actinohivin: specific amino acid residues essential for anti-HIV activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T01%3A34%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Actinohivin:%20specific%20amino%20acid%20residues%20essential%20for%20anti-HIV%20activity&rft.jtitle=Journal%20of%20antibiotics&rft.au=Takahashi,%20Atsushi&rft.date=2010-11-01&rft.volume=63&rft.issue=11&rft.spage=661&rft.epage=665&rft.pages=661-665&rft.issn=0021-8820&rft.eissn=1881-1469&rft_id=info:doi/10.1038/ja.2010.106&rft_dat=%3Cproquest_cross%3E4050397961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1787783502&rft_id=info:pmid/20842142&rfr_iscdi=true